In colorectal cancer, Yan et al. demonstrated that RUNX2 induces a stem cell phenotype in colon cancer cells by binding to BRG1 as a tight complex, thereby upregulating the transcription and expression of CD44, and promoting the invasion and migration of colon cancer cells [134]. The gene discussed is RUNX2; the disease is colonic neoplasm.